[TYPE THE COMPANY NAME]
LML4801 Assignment
2 (COMPLETE
ANSWERS) Semester
1 2026 - DUE 14 April
2026
NO PLAGIARISM
[Pick the date]
[Type the abstract of the document here. The abstract is typically a short summary of the contents of
the document. Type the abstract of the document here. The abstract is typically a short summary of
the contents of the document.]
, xam (elaborations)
LML4801 Assignment 2 (COMPLETE
ANSWERS) Semester 1 2026 - DUE 14 April
2026
LML4801 Assignment 2 (COMPLETE ANSWERS) Semester 1 2026 - DUE 14
April 2026; 100% TRUSTED Complete, trusted solutions and explanations.
Imagine that you are the patent manager for CIDSS, and you are tasked with
assisting Dr Dlamini with applying for the patent. Is there anything from the
scenario that would pose a challenge to the granting of the patent, or if the
patent is granted, anything that might lead to the revocation of the patent at
a future date (seeing as how South Africa is a non-examining jurisdiction as
far as patents are concerned).
As the Patent Manager for the Centre for Industrial Development and Social Solutions (CIDSS),
my role is to ensure that Dr. Dlamini’s invention not only reaches the registration phase but
survives the scrutiny of a potential High Court challenge.
Since South Africa is a non-examining jurisdiction, the Companies and Intellectual Property
Commission (CIPC) will grant a patent as long as the administrative paperwork is correct.
However, this creates a "false sense of security." The validity of the patent is only truly tested if
a competitor applies for its revocation under Section 61 of the Patents Act 57 of 1978.
Based on the legal requirements for patentability, here are the primary challenges we face:
1. The Challenge of "Novelty" (The Disclosure Trap)
For a patent to be valid, it must be new (novel). In South Africa, we follow a standard of
Absolute Novelty. This means the invention must not have been disclosed to the public
anywhere in the world, in any form, before the filing date.
The Risk: If Dr. Dlamini has presented her findings at a university symposium,
published an article in an academic journal, or even discussed the technical specifics in a
non-confidential setting before we file the provisional patent application, the novelty is
destroyed.
Consequence: A competitor could later present this prior publication as evidence that the
invention was part of the "state of the art," leading to the revocation of the patent.
LML4801 Assignment
2 (COMPLETE
ANSWERS) Semester
1 2026 - DUE 14 April
2026
NO PLAGIARISM
[Pick the date]
[Type the abstract of the document here. The abstract is typically a short summary of the contents of
the document. Type the abstract of the document here. The abstract is typically a short summary of
the contents of the document.]
, xam (elaborations)
LML4801 Assignment 2 (COMPLETE
ANSWERS) Semester 1 2026 - DUE 14 April
2026
LML4801 Assignment 2 (COMPLETE ANSWERS) Semester 1 2026 - DUE 14
April 2026; 100% TRUSTED Complete, trusted solutions and explanations.
Imagine that you are the patent manager for CIDSS, and you are tasked with
assisting Dr Dlamini with applying for the patent. Is there anything from the
scenario that would pose a challenge to the granting of the patent, or if the
patent is granted, anything that might lead to the revocation of the patent at
a future date (seeing as how South Africa is a non-examining jurisdiction as
far as patents are concerned).
As the Patent Manager for the Centre for Industrial Development and Social Solutions (CIDSS),
my role is to ensure that Dr. Dlamini’s invention not only reaches the registration phase but
survives the scrutiny of a potential High Court challenge.
Since South Africa is a non-examining jurisdiction, the Companies and Intellectual Property
Commission (CIPC) will grant a patent as long as the administrative paperwork is correct.
However, this creates a "false sense of security." The validity of the patent is only truly tested if
a competitor applies for its revocation under Section 61 of the Patents Act 57 of 1978.
Based on the legal requirements for patentability, here are the primary challenges we face:
1. The Challenge of "Novelty" (The Disclosure Trap)
For a patent to be valid, it must be new (novel). In South Africa, we follow a standard of
Absolute Novelty. This means the invention must not have been disclosed to the public
anywhere in the world, in any form, before the filing date.
The Risk: If Dr. Dlamini has presented her findings at a university symposium,
published an article in an academic journal, or even discussed the technical specifics in a
non-confidential setting before we file the provisional patent application, the novelty is
destroyed.
Consequence: A competitor could later present this prior publication as evidence that the
invention was part of the "state of the art," leading to the revocation of the patent.
